What is measured?
Period-average diluted EPS denominator; not period-end shares outstanding.
Oracle annual diluted weighted-average shares by fiscal year. Period-average diluted EPS shares, not shares outstanding on a single date.
5-year change · FY2021 to FY2026
Oracle's diluted weighted-average shares were 2.914B in FY2026, down 108M (3.6%) from FY2021 but up 48M (1.7%) year over year.
The displayed period-change result was separately reviewed.
A company page opens when one exists. Other searches show current availability.
Each annual value opens the SEC filing that contains the displayed fact.
Source filing is the exact SEC document used for the displayed fact, not necessarily the filing that first reported that fiscal year. Later comparative filings are labeled below.
| Fiscal year | Diluted weighted-average shares | Change from previous displayed period | Filing containing fact | Source |
|---|---|---|---|---|
| FY20262026-05-31 | 2.914B | +1.7%FY2025 to FY2026 | 10-K2026-06-22 | |
| FY20252025-05-31 | 2.866B | +1.5%FY2024 to FY2025 | 10-K (FY2026 filing)2026-06-22comparative period | |
| FY20242024-05-31 | 2.823B | +2.1%FY2023 to FY2024 | 10-K2026-06-22comparative period | |
| FY20232023-05-31 | 2.766B | -0.7%FY2022 to FY2023 | 10-K2025-06-18comparative period | |
| FY20222022-05-31 | 2.786B | -7.8%FY2021 to FY2022 | 10-K2024-06-20comparative period | |
| FY20212021-05-31 | 3.022B | -8.3%FY2020 to FY2021 | 10-K2023-06-20comparative period | |
| FY20202020-05-31 | 3.294B | -11.7%FY2019 to FY2020 | 10-K2022-06-21comparative period | |
| FY20192019-05-31 | 3.732B | -11.9%FY2018 to FY2019 | 10-K2021-06-21comparative period | |
| FY20182018-05-31 | 4.238B | +0.5%FY2017 to FY2018 | 10-K2020-06-22comparative period | |
| FY20172017-05-31 | 4.217B | -2.0%FY2016 to FY2017 | 10-K2019-06-21comparative period | |
| FY20162016-05-31 | 4.305B | -4.4%FY2015 to FY2016 | 10-K2018-06-22comparative period | |
| FY20152015-05-31 | 4.503B | n/a | 10-K2017-06-27comparative period |
Repurchase cash and SBC are SEC-reported USD measures shown for context. They are not netted and do not explain changes in diluted weighted-average shares.
| Adjustment | Basis | Accession | Source location | ||||||
|---|---|---|---|---|---|---|---|---|---|
| FY2015, period ended 2015-05-31 | 2015-05-31 | DWA shares | 4.5B | 4.5B | none | as reported | 10-K2017-06-27comparative period | 0001193125-17-214833 | Exact XBRL fact |
| FY2016, period ended 2016-05-31 | 2016-05-31 | DWA shares | 4.3B | 4.3B | none | as reported | 10-K2018-06-22comparative period | 0001193125-18-201034 | Exact XBRL fact |
| FY2017, period ended 2017-05-31 | 2017-05-31 | DWA shares | 4.2B | 4.2B | none | as reported | 10-K2019-06-21comparative period | 0001564590-19-023119 | Exact XBRL fact |
| FY2018, period ended 2018-05-31 | 2018-05-31 | DWA shares | 4.2B | 4.2B | none | as reported | 10-K2020-06-22comparative period | 0001564590-20-030125 | Exact XBRL fact |
| FY2019, period ended 2019-05-31 | 2019-05-31 | DWA shares | 3.7B | 3.7B | none | as reported | 10-K2021-06-21comparative period | 0001564590-21-033616 | Exact XBRL fact |
| FY2020, period ended 2020-05-31 | 2020-05-31 | DWA shares | 3.3B | 3.3B | none | as reported | 10-K2022-06-21comparative period | 0001564590-22-023675 | Exact XBRL fact |
| FY2021, period ended 2021-05-31 | 2021-05-31 | DWA shares | 3.0B | 3.0B | none | as reported | 10-K2023-06-20comparative period | 0000950170-23-028914 | Exact XBRL fact |
| FY2022, period ended 2022-05-31 | 2022-05-31 | DWA shares | 2.8B | 2.8B | none | as reported | 10-K2024-06-20comparative period | 0000950170-24-075605 | Exact XBRL fact |
| FY2023, period ended 2023-05-31 | 2023-05-31 | DWA shares | 2.8B | 2.8B | none | as reported | 10-K2025-06-18comparative period | 0000950170-25-087926 | Exact XBRL fact |
| FY2024, period ended 2024-05-31 | 2024-05-31 | DWA shares | 2.8B | 2.8B | none | as reported | 10-K2026-06-22comparative period | 0001193125-26-277521 | Exact XBRL fact |
| FY2025, period ended 2025-05-31 | 2025-05-31 | DWA shares | 2.9B | 2.9B | none | as reported | 10-K (FY2026)2026-06-22comparative period | 0001193125-26-277521 | Exact XBRL fact |
| FY2026, period ended 2026-05-31 | 2026-05-31 | DWA shares | 2.9B | 2.9B | none | as reported | 10-K (FY2026)2026-06-22 | 0001193125-26-277521 | Exact XBRL fact |
Each row connects a displayed value to an SEC filing and taxonomy tag. Open Technical details for the XBRL context, unit, decimals, and dimensions available for that row.
| Period | Metric | Chart value | Filing | Accession | Taxonomy tag | Source location | Source |
|---|---|---|---|---|---|---|---|
| value | links | ||||||
| FY2015, period ended 2015-05-312015-05-31 | DWA shares | 4.5B | 10-K2017-06-27comparative period | 0001193125-17-214833 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView XBRL sourceCompany Facts |
| FY2016, period ended 2016-05-312016-05-31 | DWA shares | 4.3B | 10-K2018-06-22comparative period | 0001193125-18-201034 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView XBRL sourceCompany Facts |
| FY2017, period ended 2017-05-312017-05-31 | DWA shares | 4.2B | 10-K2019-06-21comparative period | 0001564590-19-023119 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView XBRL sourceCompany Facts |
| FY2018, period ended 2018-05-312018-05-31 | DWA shares | 4.2B | 10-K2020-06-22comparative period | 0001564590-20-030125 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2019, period ended 2019-05-312019-05-31 | DWA shares | 3.7B | 10-K2021-06-21comparative period | 0001564590-21-033616 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2020, period ended 2020-05-312020-05-31 | DWA shares | 3.3B | 10-K2022-06-21comparative period | 0001564590-22-023675 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2021, period ended 2021-05-312021-05-31 | DWA shares | 3.0B | 10-K2023-06-20comparative period | 0000950170-23-028914 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2022, period ended 2022-05-312022-05-31 | DWA shares | 2.8B | 10-K2024-06-20comparative period | 0000950170-24-075605 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2023, period ended 2023-05-312023-05-31 | DWA shares | 2.8B | 10-K2025-06-18comparative period | 0000950170-25-087926 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2024, period ended 2024-05-312024-05-31 | DWA shares | 2.8B | 10-K2026-06-22comparative period | 0001193125-26-277521 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2025, period ended 2025-05-312025-05-31 | DWA shares | 2.9B | 10-K (FY2026)2026-06-22comparative period | 0001193125-26-277521 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
| FY2026, period ended 2026-05-312026-05-31 | DWA shares | 2.9B | 10-K (FY2026)2026-06-22 | 0001193125-26-277521 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | Exact XBRL factTechnical details
| View filingView source documentCompany Facts |
Period-average diluted EPS denominator; not period-end shares outstanding.
Changes compare matching fiscal-year observations. A window is unavailable unless its exact start and end fiscal years are present in the checked series.
Repurchase cash and stock-based compensation are contextual USD measures. They are not components of the share-count calculation and do not establish causation.
The displayed period-change result was separately reviewed.
Use the source trace and displayed data table to inspect filing, accession, period, unit, and XBRL trace.
Not investment advice. This page describes what filings report about share counts — research and education only, not investment, trading, tax, legal, or personalized financial advice.